Metastatic brain tumors -- tumors that spread from a cancer in another area of the body -- are among the worst tumors and will plague about 200,000 people in the United States every year. But once considered a death sentence, these brain tumors -- primarily those one centimeter in size or less -- can now be treated with a breakthrough radiation technique launched at the University of Florida College of Medicine. This new state-of-the-art radiosurgery device for noninvasive, outpatient treatment is more precise and more powerful than previous methods of treatment. Approved by the FDA in June, this Trilogy Tx system makes traditional surgery unnecessary for many patients. Dr. William Friedman, chairman for the department of neurosurgery at UF and one of two professors who developed and patented seven components of this system over the past 20 years, says, "I'm a surgeon, but if you can provide an outpatient, noninvasive treatment that requires no anesthesia, has extremely high cure rates, and very low complication rates, the question is: Why do surgery?"
Patients of this treatment are fitted with a head ring that prevents the their heads from moving while the Trilogy machine rotates to deliver radiation beams from many angles. While traditional radiation is given every day, Monday through Friday, for six weeks, the Trilogy Tx requires one single treatment that lasts for 15 minutes. It's comparable in cost to standard radition, is cheaper than surgery, and is typically covered by insurance. And it works -- which is the best selling feature, I think.